Atossa Genetics Inc news

   Watch this stock
Showing stories 1 - 10 of about 81   

Articles published

ATOS 1.58 -0.04 (-2.47%)
price chart
Atossa Genetics (ATOS) Stock Declines Today on Heavy Trading Volume
"We rate ATOSSA GENETICS INC (ATOS) a SELL. This is driven by several weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the ...
Know before you invest: Atossa Genetics Inc (NASDAQ:ATOS), American ...  Markets Emerging
Atossa Genetics Inc (NASDAQ:ATOS): This Stock May Be Undervalued  USMarketsDaily (blog)
Related articles »  
Atossa Genetics Announces 2014 Financial Results and Provides Company ...
SEATTLE, WA, Mar 30, 2015 (Marketwired via COMTEX) -- Atossa Genetics, Inc. ATOS, +7.30% today announced 2014 financial results and provided an update on recent company developments.
Atossa Genetics' (ATOS) CEO Steven Quay on Q4 2014 Results - Earnings ...  Seeking Alpha (registration)
Atossa Genetics: Spotty Track Record And Short On Cash (ATOS)
As a result the company improperly marketed its devices by using certain promotional claims to market the product not supported by the FDA.
Why gaining sharply? - Atossa Genetics Inc (ATOS), Penn Virginia Corporation ...  Markets Emerging
Atossa Genetics (ATOS) Gains; Henry Schein to Offer FullCYTE Breast Aspirator  StreetInsider.com
Atossa Genetics (ATOS) Reports In-Network Contract With Meridian Health Plan ...
Atossa Genetics Inc. (NASDAQ: ATOS) announced today that its wholly-owned subsidiary, The National Reference Laboratory for Breast Health Inc. (NRLBH), has been credentialed as an in-network provider for its Pharmacogenetic and Nipple Aspirate Fluid ...
Atossa Genetics Secures In-Network Contract With Meridian Health Plan of ...  Marketwired (press release)
Atossa Genetics Inc. Provides Update on Pharmacogenetics Testing Now ...
SEATTLE, WA, Dec 19, 2014 (Marketwired via COMTEX) -- Atossa Genetics Inc. ATOS, +0.00% today announced that its subsidiary, The National Reference Laboratory for Breast Health, Inc. (the NRLBH), a CLIA-certified laboratory located in Seattle, ...
Related articles »  
Atossa Genetics launches breast cancer products in Europe (ATOS)
Nano cap Atossa Genetics (NASDAQ:ATOS) is up 17% premarket on robust volume on its announcement that the commercial launch of its ForeCYTE Breast Aspirator and Collection Kit within the European Union in underway.
Seattle's Atossa Genetics completes pint-size IPO
After nearly nine months, Atossa Genetics of Seattle completed its initial public stock offering Thursday. But the final deal was even smaller than what the breast-cancer diagnostics company originally - and as recently as this week - had hoped ...
Atossa Genetics (ATOS) IPO Trades Lower  StreetInsider.com (subscription)
Related articles »  
Atossa Genetics: My Top Biotech Idea For 2013
The name of the company is Atossa Genetics (NASDAQ:ATOS). I am so excited about the prospects of this company that I am naming it my best biotech idea for the year. Atossa Genetics is at the forefront of breakthrough procedures to make breast cancer a ...
Atossa Genetics: Pure Play Breast Care Biotech With Favorable Risk/Reward ...
Atossa, through its subsidiary, the National Reference Laboratory for Breast Health, Inc. (the NRLBH), is offering pharmacogenetics (PG) testing for patients.
Atossa Genetics Launches the FullCYTE Breast Aspirator in the United States
Atossa Genetics Inc. is focused on improving breast health through the development of laboratory services, medical devices and therapeutics.
Atossa Genetics (ATOS) Announces Launch of FullCYTE Breast Aspirator in US  StreetInsider.com